Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
LLY News
Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...
While President Donald Trump's proposed 200% tariffs on pharmaceutical imports could potentially squeeze the profit margins, this stock is poised to “benefit” f...
JPMorgan (JPM) just gave Eli Lilly (LLY) stock a fresh shot of adrenaline — a new $1,100 forecast and a bullish Buy rating that has Wall Street watching every m...
Analyst ratings
83%
of 30 ratingsMore LLY News
Eli Lilly (LLY) has received another bullish report ahead of its upcoming earnings on August 7. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks...
Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 5...
Eli Lilly and Co. LLY is set to release its second-quarter earnings on August 7. According to Benzinga Pro data, analysts are anticipating adjusted earnings of...
...
recently received FDA approval for a new dosing schedule of Kisunla, aimed at reducing amyloid-related imaging abnormalities in Alzheimer's treatment. This deve...
The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s LLY Kisunla (do...
Imports of peptides and protein-based hormones — the category that GLP-1 weight-loss drugs fall under — from Ireland are already more than double than last year...
